Watchful waiting is an alternative to active treatment for men with low risk prostate cancer but...
To evaluate the primary causes of death in low-risk (low-risk), intermediate-risk (intermediate-...
Increasing the number of prostate biopsy cores from 10 to 18 is reported to increase the prostat...
Prior studies have reported that men with a PSA density (PSAD) less than 0.15, less than 3 posit...
There was 1 positive core in 66 cases. On average 13.9% of each positive core was involved with ...
Cancer control after radical prostatectomy improves with increasing surgeon experience irrespect...
For patients with bone metastases, high N-telopeptide of type I collagen (NTX) levels correlate ...
To perform a retrospective analysis to assess the utility of pretreatment serum prostatic acid p...
Transperineal and transrectal prostate biopsy are both used for prostate cancer detection. Howev...
The time to testosterone recovery after the cessation of androgen deprivation therapy appears to...
To investigate the influence of androgen deprivation therapy (ADT) in men with nonmetastatic pro...
Pretreatment prostate specific antigen (PSA) is a strong predictor of prostate cancer outcome af...
It has been hypothesized that abnormal p53 protein expression is associated with a worse prognos...
NOTE: This is an interesting study that show those who had radiation and showed success as per ...
The incidence of histologic prostate cancer (CaP) after definitive radiation therapy (RT) for lo...
Recent studies have demonstrated that the percentage of positive prostate needle biopsies (PPBs)...
This study aimed to address long-term survival in a large population-based cohort of men with pr...
To determine the incidence of second primary cancers (SPCs) and radiotherapy-induced SPCs (RTSPC...
We examined consumption of animal foods, protein and calcium in relation to risk of prostate can...
To assess the efficacy of salvage radiotherapy (RT) for persistent or rising PSA after radical p...
The length of positive margin is significantly associated with disease progression. The Gleason ...
Mucinous adenocarcinoma of the prostate is one of the least common variants of prostate cancer. ...
We conducted the present study to evaluate the safety profile and therapeutic value of a combina...
To determine whether adding 2 years of androgen-deprivation therapy (ADT) improved outcome for p...
Docetaxel is standard of care for androgen-independent prostate cancer (AIPC). Doxercalciferol ...
We tested the hypothesis that a single exogenous androgen injection in men with low prostate spe...